Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui-Lan Fan

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Chemical Communications (Cambridge, England)|August 1, 2020
Collective enantioselective total synthesis of (+)-sinensilactam A, (+)-lingzhilactone B and (-)-lingzhiol: divergent reactivity of styreneDa-Wei Zhang, Hui-Lan Fan, Wenzhao Zhang, et al.
Organic Letters|August 22, 2019
Total Synthesis of (±)-Cochlearol ADa-Wei Zhang, Wen-Dan Xu, Hui-Lan Fan, et al.
Human Vaccines & Immunotherapeutics|May 16, 2025
Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trialXiao-Qiang Liu, Yang-Yang Qi, Tao Huang, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Chemical Communications (Cambridge, England)|August 1, 2020
Collective enantioselective total synthesis of (+)-sinensilactam A, (+)-lingzhilactone B and (-)-lingzhiol: divergent reactivity of styreneDa-Wei Zhang, Hui-Lan Fan, Wenzhao Zhang, et al.
Organic Letters|August 22, 2019
Total Synthesis of (±)-Cochlearol ADa-Wei Zhang, Wen-Dan Xu, Hui-Lan Fan, et al.
Human Vaccines & Immunotherapeutics|May 16, 2025
Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trialXiao-Qiang Liu, Yang-Yang Qi, Tao Huang, et al.
Pageof 1